Covid Janssen vaccine | Filtered the date of the European opinion: March 11

Covid Janssen vaccine | Filtered the date of the European opinion: March 11


If approved within that period, this immunization would not reach Spain until April, as confirmed by Health

The European Medicines Agency (EMA, for its acronym in English) plans to approve the vaccine against the coronavirus Covid-19 from the pharmaceutical company Johnson & Johnson on March 11, as assured this Friday.

If authorized, it would be the fourth coronavirus vaccine approved in the European Union, thus adding to that of Moderna, AstraZeneca and Pfizer. Although the EMA has not yet officially confirmed the news, last week it already announced that it planned to issue an opinion in mid-March on the approval of the Johnson & Johnson vaccine, which has already sent the official request to obtain the license for use. of your vaccine.

For its part, the French pharmaceutical multinational Sanofi announced on Monday an agreement to manufacture 12 million monthly doses of the vaccine candidate against Covid-19 from Janssen, from the American laboratory Johnson & Johnson, once it receives authorization from the European authorities.

The same source also pointed out to the news agency that talks are continuing with the Russian authorities about its ‘Sputnik V’ vaccine and that they hope to receive new data soon to begin a review process.

Janssen’s vaccine will arrive in Spain in April

As announced by the Minister of Health, Carolina Darias, during her appearance at the Health Commission, the Janssen Covid-19 vaccine could arrive in Spain in April, if the estimated approval deadlines are met. by the EMA.

Specifically, Darias confirmed in parliament that the company will not begin to supply it until April “by contract.” “We hope that, as the second quarter goes by, it will pick up speed,” she has stressed.